Venture Round - Prognos Health

Venture Round - Prognos Health

Investment Firm

Overview

Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.

Announced Date

May 04, 2023

Funding Type

Series Unknown

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Safeguard Scientifics

Safeguard Scientifics

Safeguard Scientifics is a early_stage_venture and late_stage_venture and private_equity firm.

Marshall Wace

Marshall Wace

Marshall Wace is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

7

Investor Name
Participant InvestorMaywic Select Investments
Participant InvestorLabCorp
Participant InvestorMerck
Participant InvestorCigna
Participant InvestorSafeguard Scientifics

Round Details and Background

Prognos Health raised $23288367 on 2023-05-04 in Venture Round

Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 04, 2023
Venture Round - Prognos Health
9-23.3M
Aug 18, 2011
Convertible Note - Prognos Health
1-745.0K
Jun 17, 2013
Series B - Prognos Health
3-15.0M
Nov 17, 2011
Series A - Prognos Health
3-7.0M

Recent Activity

There is no recent news or activity for this profile.